CLINICAL DATA.
FULL EVIDENCE.
FOR PROFESSIONALS.
Access comprehensive prescribing information, Phase III trial results, dosing guides and drug interaction data for pandozab (pandovirumab).
This section is intended exclusively for licensed healthcare professionals including physicians, pharmacists and nurses.
3
Phase III clinical trials
4,200+
patients enrolled across trials
87%
achieved target blood pressure
18
approved markets globally
WHAT'S IN THE HCP PORTAL?
Everything you need to prescribe pandozab with confidence
Phase III Trial Data
Full efficacy and safety results from the pivotal PANDORA-1, -2 and -3 studies.
Dosing & Administration
Recommended dosing regimens, titration guidance and special population considerations.
Drug Interactions
Comprehensive interaction profiles and contraindication information.
Prescribing Information
Full SmPC and patient information leaflet for clinical use.
CONFIRM YOUR PROFESSIONAL STATUS
Please confirm the following before entering the HCP portal
You are a qualified healthcare professional
Including physicians, pharmacists, nurses and other licensed medical practitioners.
You are acting in a professional capacity
This information is being accessed for clinical or prescribing purposes only.
Content is not for patients
You understand this material is not intended for patients or the general public.
Pandozab is approved in your country
You are located in a jurisdiction where pandozab is approved for use.
This section is intended for healthcare professionals only. If you are a patient, please return to the main site.